Pfizer Sells $1 Billion Bond Funding Vaccine Production – Bloomberg

Proceeds from the sale are marked for research and development expenses and the manufacturing and distribution of Covid-19 vaccines. The New York-based pharmaceutical company sees the vaccine bringing in $33.5 billion of revenue this year, which would make it one of the top-selling medicines ever.

http://archive.today/2021.09.06-162254/https://www.bloomberg.com/news/articles/2021-08-16/pfizer-to-sell-sustainability-bond-funding-vaccine-production